UAE Aims for 90% HPV Vaccination Coverage in Schoolgirls by 2030

The United Arab Emirates has unveiled an ambitious plan to vaccinate 90% of schoolgirls aged 13 to 14 against the human papillomavirus by 2030, aiming to significantly reduce the incidence of cervical cancer nationwide. This initiative underscores the country's commitment to preventive healthcare and aligns with global efforts to combat HPV-related diseases.

HPV is a prevalent sexually transmitted infection responsible for the majority of cervical cancer cases. Recognizing the critical role of vaccination in preventing such cancers, the UAE's Ministry of Health and Prevention has integrated the HPV vaccine into the National Immunisation Programme. Initially introduced for female students in 2018, the programme expanded in 2023 to include male students aged 13 to 14, reflecting a comprehensive approach to disease prevention.

The World Health Organization has commended the UAE for its proactive stance, highlighting the nation's adherence to high standards in combating HPV and cervical cancer. This recognition positions the UAE as a regional leader in public health initiatives. Dr. Hussein Abdul Rahman Al Rand, Assistant Undersecretary for the Public Health Sector, emphasized that such achievements result from collaborative efforts among health authorities and strategic partners dedicated to developing policies grounded in scientific research.

In pursuit of the 90% vaccination target, the UAE has implemented several key strategies:

1. Mandatory Vaccination for Schoolgirls: Starting from the academic year following the vaccine's inclusion in the National Immunisation Programme, the HPV vaccine became free and compulsory for all schoolgirls in Dubai and the Northern Emirates. This policy ensures equitable access and aims to boost vaccination rates among the target age group.

2. Public Awareness Campaigns: Health authorities have launched extensive campaigns to educate the public about the importance of HPV vaccination. These initiatives focus on encouraging young women, particularly those aged 13 to 26, to receive the vaccine before marriage, thereby enhancing its preventive efficacy.

3. Integration into School Health Services: Collaborations with educational institutions facilitate the administration of vaccines within schools, streamlining the process and increasing accessibility for students.

The UAE's efforts are set against the backdrop of WHO's updated recommendations, which now endorse a one or two-dose schedule for girls aged 9 to 14 years. This simplified regimen is expected to improve vaccine uptake globally, a development that aligns with the UAE's streamlined vaccination protocols.